Orgovyx 120 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FW4HU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,252
Award facts
- Contract value 100% obligated
- $33,252.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $33.25K delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion prime vendor agreement designated SPE2DX and active through December 2026. The delivery order is scheduled for completion by October 16, 2025, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This award reflects AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal military and veteran healthcare systems. Orgovyx is a specialized oncology medication used in prostate cancer treatment, consistent with the company's extensive portfolio of brand-name and generic pharmaceuticals supplied through the DLA Medical Supply Chain. The award was not subject to a set-aside designation, indicating AmerisourceBergen competed successfully in an open procurement process. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative, under which this supply falls, is designed to leverage multiple regional contractors to ensure comprehensive global pharmaceutical support for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FW4HU?
SPE2DB25FW4HU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FW4HU worth?
The government has obligated $33,252 on SPE2DB25FW4HU.
Is contract SPE2DB25FW4HU an order under another contract?
Yes. SPE2DB25FW4HU is a delivery order under SPE2DB22D2006, an indefinite delivery contract.
Was contract SPE2DB25FW4HU competed?
The extent of competition for SPE2DB25FW4HU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award